Use Sonography in Patients With Intrauterine Device Presenting With Bleeding

Contraception Clinical Trial

Official title:

Intrauterine Contraceptive Device:Clinical and Sonographic Correlation in Patients Presenting With Bleeding

Clinical Trial Details — Status: Not yet recruiting

Administrative data

• NCT number: NCT03140800
• Other study ID #: IUD
• Status: Not yet recruiting
• Phase: N/A
• First received: May 3, 2017
• Last updated: May 3, 2017
• Start date: June 2017
• Est. completion date: March 2019

Study information

• Verified date: May 2017
• Source: Assiut University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Intrauterine contraceptive device is one of the most efficient and reversible methods of birth control with low cost and long duration of use However, in the first year after insertion, between 5 and 15% of women will have their Intrauterine contraceptive device removed because of irregular uterine bleeding which have been attributed to the effect of contact between the device and the endometrium and even the pressure on the uterine muscle . The disharmonious relationship between the Intrauterine contraceptive device and the uterus is the cause of most of the bleeding complaints, so bleeding is related to improper position rather than the contraceptive method itself which should be excluded before abandoning the Intrauterine contraceptive device for any other method of birth control

Recruitment information / eligibility

• Status: Not yet recruiting
• Enrollment: 60
• Est. completion date: March 2019
• Est. primary completion date: August 2018
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: N/A and older

Eligibility

Inclusion Criteria:

patients using intrauterine contraceptive device complaining of bleeding

Exclusion Criteria:

• a-Associated uterine, cervical,or adenexal pathology b-Associated pelvic infection c-Generalized bleeding disorders d-Medications causing coagulation defects e-Medical disorders causing bleeding e.g hypertention f-Endocrine disorder as thyroid dysfunction g-Who refuse to share in the study

Related Conditions & MeSH terms

• Contraception

Intervention

Device:
• intrauterine device
a method of contraception inserted in the uterus

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Assiut University

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	The intrauterine device-Endometrial distance		3 months